Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs.
Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs.
复制标题
含热溶解CpG的DNA寡核苷酸作为潜在的免疫治疗前药。
DOI:
10.1093/nar/gki657
复制
发表时间:
2005
影响因子:
14.9
通讯作者:
Beaucage, SL
中科院分区:
文献类型:
--
作者:
Grajkowski, A;Pedras-Vasconcelos, J;Wang, VV;Ausín, C;Hess, S;Verthelyi, D;Beaucage, SL
A CpG-containing DNA oligonucleotide functionalized with the 2-(N-formyl-N-methyl)aminoethyl thiophosphate protecting group (CpG ODN fma1555) was prepared from phosphoramidites 1a–d using solid-phase techniques. The oligonucleotide behaved as a prodrug by virtue of its conversion to the well-studied immunomodulatory CpG ODN 1555 through thermolytic cleavage of the 2-(N-formyl-N-methyl)aminoethyl thiophosphate protecting group. Such a conversion occurred at 37°C with a half-time of 73 h. The immunostimulatory properties of CpG ODN fma1555 were evaluated in two in vivo assays, one of which consisted of mice challenged in the ear with live Leishmania major metacyclic promastigotes. Local intradermal administration of CpG ODN fma1555 was as effective as that of CpG ODN 1555 in reducing the size of Leishmania lesions over time. In a different infectious model, CpG ODN 1555 prevented the death of Tacaribe-infected mice (43% survival) when administered between day 0 and 3 post infection. Administration of CpG ODN fma1555 three days before infection resulted in improved immunoprotection (60–70% survival). Moreover, co-administration of CpG ODN fma1555 and CpG ODN 1555 in this model increased the window for therapeutic treatment against Tacaribe virus infection, and thus supports the use of thermolytic oligonucleotides as prodrugs in the effective treatment of infectious diseases.
登录
查看更多内容
影响因子:
3.6
作者:
IYER, RP;PHILLIPS, LR;BEAUCAGE, SL
通讯作者:
BEAUCAGE, SL
DOI:
10.1039/b101754n
发表时间:
2001-01-01
期刊:
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2
影响因子:
--
作者:
Ora, M;Mäki, E;Lönnberg, H
通讯作者:
Lönnberg, H
影响因子:
46.9
作者:
Agrawal, S;Kandimalla, ER
通讯作者:
Kandimalla, ER
影响因子:
2.7
作者:
BARBER, I;RAYNER, B;IMBACH, JL
通讯作者:
IMBACH, JL
影响因子:
14.9
作者:
Boal, JH;Wilk, A;Beaucage, SL
通讯作者:
Beaucage, SL